Destination XL (DXLG) Q3 2025 Earnings Transcript

Image source: The Motley Fool. DATE Thursday, December 4, 2025 at 9 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Harvey Kanter Incoming Chief Executive Officer (post-merger) — James Fogarty Chief Financial Officer — Peter Stratton TAKEAWAYS Net Sales — $101.9 million, down from $107.5 million, driven primarily by a 7.4% decrease in comparable sales, […]

Albertsons (ACI) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, January 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Interim Chief Executive Officer — Susan Morris President and Chief Financial Officer — Sharon McCollam Need a quote from a Motley Fool analyst? Email [email protected] TAKEAWAYS Identical Sales — Increased 2.4% with government shutdown and SNAP delays imposing a […]

Cal-Maine Foods (CALM) Q2 2026 Earnings Transcript

Image source: The Motley Fool. DATE Wednesday, January 7, 2026 at 9 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Sherman Miller Vice President and Chief Financial Officer — Max P. Bowman TAKEAWAYS Net Sales — $769.5 million, down 19.4%, driven by 26.5% lower shell egg selling prices and a 2.2% decline in […]

The Builder’s Notes: Your Patient Data Is Being Sold.

The Builder’s Notes: Your Patient Data Is Being Sold. You Don’t Know, Don’t Consent, and Get Nothing. Hospitals sell your medical records to AI companies, pharmaceutical firms, hedge funds, and insurers for $15M+ annually. You never consented. You’ll never know who bought your data or how they used it. You receive $0. Here’s how the patient […]

Robard Launches Biocare2™

Addressing the Nutritional Gap as Appetite Returns and Metabolism Shifts After Stopping GLP-1 Use MOUNT LAUREL, N.J., Jan. 7, 2026 /PRNewswire/ — As individuals move beyond GLP-1 use, a new challenge has emerged: supporting nutrition and metabolic health as appetite returns. Today,…

This weight loss option beats Ozempic by 5 times

Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two years after treatment, surgery patients lost about 58 pounds on average, while those using semaglutide or tirzepatide lost roughly 12 pounds. Even patients who stayed on GLP-1 drugs for a full year saw much smaller results […]

Fast-food menus bulk up on protein in the GLP-1 era – Axios

Fast-food menus bulk up on protein in the GLP-1 era  Axios Subway Launches a High-Protein Item at a Low Price  foodnetwork.com 5 restaurant resolutions for 2026, plus the explosion in protein and implosion of Sprinkles  Nation’s Restaurant News Subway Canada rolls out Fresh Fit sandwich range  Verdict Food Service Subway Is Rolling Out 4 New Menu Items, and We […]